Allena Pharmaceuticals, Inc. Gains 114.29%
Wed, Jun 29, 2022 at 08:16 PM
Allena Pharmaceuticals, Inc. (ALNA:NASDAQ) rocketted at $0.26, representing a gain of 114.3%. On Wed, Jun 29, 2022, ALNA:NASDAQ hit a New 2-Week High of $0.26. From Wed, Jun 15, 2022, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Wed, Jun 29, 2022 at $0.44 with a volume of 566M+.
About Allena Pharmaceuticals, Inc. (ALNA:NASDAQ)
Allena Pharmaceuticals Inc is a clinical biopharmaceutical company. It focuses on developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.
Top 10 Gainers:
- Allena Pharmaceuticals, Inc. (ALNA:NASDAQ), 114.29%
- Brickell Biotech, Inc. (BBI:NASDAQ), 47.64%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 44.15%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Aeterna Zentaris Inc. (AEZS:NASDAQ), 39.98%
- Aditxt Inc. (ADTX:NASDAQ), 39.76%
- PARTS iD Inc. Class A (ID:NYSEMKT), 38.24%
- Avenue Therapeutics, Inc. (ATXI:NASDAQ), 32.04%
- Grove Collaborative Holdings Inc. Class A (GROV:NYSE), 29.45%
- 9F Inc. (JFU:NASDAQ), 28.01%